Loading company…
Minglan Shijia provides digital services for female reproductive health and cervical cancer screening.
Minglan Shijia developed Mevixaga, a system for interpreting cervical cancer screening reports and supporting screening, diagnosis, and treatment. The company plans to develop a digital service for cervical epithelial lesion screening and treatment. Established in 2022 and based in Beijing, China, it raised seed funding from Marathon Venture Partners in July 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in